menu Search
Arexvy

Arexvy

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline Biologicals

Distributor:

GlaxoSmithKline
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Resp syncytial virus (RSV) vaccine (recombinant, adjuvanted) (RSVPreF3 antigen, AS01E adjuvant system)
Indications/Uses
Active immunisation for prevention of lower resp tract disease caused by RSV in adults ≥60 yr & in adults 50-59 yr who are at increased risk for RSV disease.
Click to view Arexvy detailed prescribing information
Dosage/Direction for Use
IM Single dose of 0.5 mL inj, preferably in deltoid muscle.
Click to view Arexvy detailed prescribing information
Overdosage
View Arexvy overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Arexvy detailed prescribing information
Special Precautions
Always administer at different inj sites if to be given at the same time as another injectable vaccine. Postpone vaccination in individuals suffering from acute severe febrile illness. Do not administer intravascularly or intradermally. Caution in individuals w/ thrombocytopenia or any coagulation disorder following IM administration. Patients receiving immunosuppressive treatment or those w/ immunodeficiency may have reduced immune response to Arexvy. Minor influence on ability to drive & use machines. Not recommended during pregnancy & in breast-feeding/lactating women. Safety & efficacy in childn have not been established.
Click to view Arexvy detailed prescribing information
Use In Pregnancy & Lactation
Click to view Arexvy detailed prescribing information
Adverse Reactions
Headache; myalgia, arthralgia; inj site pain & erythema, fatigue. Inj site swelling, fever, chills.
Click to view Arexvy detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Arexvy detailed prescribing information
Storage
View Arexvy storage conditions for details to ensure optimal shelf-life.
Description
View Arexvy description for details of the chemical structure and excipients (inactive components).
Action
View Arexvy mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.
Regulatory Classification
Rx
Presentation/Packing
Form
Arexvy powd & susp for susp for inj 120 mcg/0.5 mL
Packing/Price
(1 vial of antigen powd + 1 vial of adjuvant susp) 1's